Comparative Pharmacology
Head-to-head clinical analysis: BUTALBITAL ASPIRIN AND CAFFEINE versus CHILDREN S ELIXSURE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BUTALBITAL ASPIRIN AND CAFFEINE versus CHILDREN S ELIXSURE.
BUTALBITAL, ASPIRIN AND CAFFEINE vs CHILDREN'S ELIXSURE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Butalbital is a barbiturate that enhances GABA-A receptor activity, producing sedation and anxiolysis. Aspirin irreversibly inhibits cyclooxygenase-1 and -2, reducing prostaglandin and thromboxane synthesis, leading to analgesic and antipyretic effects. Caffeine is a methylxanthine that antagonizes adenosine receptors, causing vasoconstriction and enhancing analgesia.
Acetaminophen: weakly inhibits cyclooxygenase (COX) in central nervous system, reduces prostaglandin synthesis, elevates pain threshold, and acts on hypothalamic heat-regulating center to lower body temperature. Chlorpheniramine: first-generation antihistamine; competitively antagonizes histamine at H1 receptors, reducing allergic symptoms. Dextromethorphan: noncompetitive NMDA receptor antagonist and sigma-1 agonist; suppresses cough by elevating threshold in medullary cough center. Pseudoephedrine: indirectly acting sympathomimetic; releases norepinephrine from presynaptic terminals, causing vasoconstriction and nasal decongestion.
1-2 tablets (each containing butalbital 50 mg, aspirin 325 mg, caffeine 40 mg) orally every 4 hours as needed, not to exceed 6 tablets per day.
No established adult dose; product is specifically indicated for pediatric use only. Not recommended for adults.
None Documented
None Documented
Aspirin (low dose): 2–3 hours; at high doses or in overdose, elimination half-life may prolong to 15–30 hours due to saturation of hepatic conjugation. Butalbital: 35–55 hours (mean ~45 h) with extensive accumulation on repeated dosing. Caffeine: 3–7 hours in healthy adults; prolonged in liver disease or pregnancy.
Terminal half-life: 4–6 hours in children with normal hepatic function; prolonged to >8 hours in hepatic impairment or overdose.
Aspirin (salicylate) is excreted primarily renally (50–80% as free salicylate and metabolites including salicyluric acid, gentisic acid, and glucuronide conjugates), with dose-dependent kinetics. Butalbital is renally excreted (60–70% as unchanged drug and metabolites, primarily 5-allyl-5-isobutylbarbituric acid). Caffeine is renally excreted (1–3% unchanged, 70–80% as paraxanthine, theobromine, theophylline, and their glucuronides). Biliary/fecal excretion is negligible for all components.
Renal elimination: ~90% as unchanged drug and active metabolite paracetamol glucuronide/sulfate conjugates; biliary/fecal: <5%.
Category D/X
Category C
NSAID / Antiplatelet
NSAID